Research programme: protein tyrosine phosphatase 1B inhibitors - Astex Therapeutics
Alternative Names: Protein tyrosine phosphatase 1B inhibitors research programme - Astex TherapeuticsLatest Information Update: 23 May 2006
At a glance
- Originator Astex Therapeutics
- Class
- Mechanism of Action Protein tyrosine phosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity; Type 2 diabetes mellitus
Most Recent Events
- 23 May 2006 No development reported - Preclinical for Obesity in USA (unspecified route)
- 23 May 2006 No development reported - Preclinical for Type-2 diabetes mellitus in USA (unspecified route)
- 24 Feb 2004 Preclinical trials in Obesity in USA (unspecified route)